Key result
Conservative medical therapy resolves delayed-onset HIT from a heparin-bonded PTFE graft without requiring explantation.
Case Report (n=1)
Heparin-bonded grafts may cause delayed-onset HIT, which can be managed conservatively with non-heparin anticoagulants without requiring graft explantation.
Answers are grounded in this paper and cite their sources.
May suggest heparin-bonded grafts as a rare delayed HIT trigger amenable to conservative therapy; leaves open need for confirmatory data.
A 74-year-old man who underwent a left axillofemoral heparin-bonded polytetrafluoroethylene bypass grafting surgery presented acutely ill to the hospital one month later with a dehisced left groin surgical site wound and hypotension. Patient also found to be thrombocytopenic to 79K/uL on admission, nadiring to 15 K/uL by hospital day 7. New deep vein thromboses prompted heparin induced thrombocytopenia (HIT) screening leading to a diagnosis of HIT. The patient's last known heparin administration was 36 days prior to admission as flushes during the left axillofemoral bypass surgery, making the heparin-bonded graft the only source of heparin in his body at the time of HIT diagnosis. The patient was treated with argatroban, successfully bridged to warfarin with improvement in platelet counts. Graft explantation was not required. We believe that heparin-bonded grafts have the potential to lead to HIT. However, treatment can be conservative without the need for graft explantation.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2023) conducted a case report in Heparin-induced thrombocytopenia (n=1). Heparin-bonded PTFE axillofemoral bypass graft was evaluated on Heparin-induced thrombocytopenia. A heparin-bonded PTFE axillofemoral bypass graft was suspected to cause delayed-onset heparin-induced thrombocytopenia, which was successfully treated without graft explantation.
Synapse has enriched 10 related papers. Consider them for comparative context: